Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cholangiocarcinoma × Oxaliplatin × Clear all

Phase

Status

Completed 14 Recruiting 9 Unknown 7 Not yet recruiting 4 Active not recruiting 3 Terminated 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 18 Rectal Neoplasms 10 Colonic Neoplasms 8 Neoplasm Metastasis 7 Carcinoma, Hepatocellular 6 Stomach Neoplasms 3 Pancreatic Neoplasms 3 Recurrence 2 Esophageal Neoplasms 2 Adenocarcinoma Of Esophagus 2 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Motor Activity 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Gallbladder Neoplasms 1 Esophagogastric Cancer 1 Esophageal Squamous Cell Carcinoma 1 Clinical Stage I Gastric Cancer AJCC v8 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1 Adenocarcinoma 1

Interventions

Gemcitabine 4 Cisplatin 3 infigratinib 2 Fluorouracil 2 niraparib 1 lenvatinib 1 galactomannan 1 fludarabine 1 famitinib 1 dostarlimab 1 atezolizumab 1 aldesleukin 1 Taxes 1 Sildenafil Citrate 1 Sevoflurane 1 Platinum 1 Photochemotherapy 1 Oxaliplatin 1 Observation 1 NVP-BKM120 1 Interviews as Topic 1 IMC-001 1 Desflurane 1 Cyclophosphamide 1 Capecitabine 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00713687 2012-08-10

GemOx-PDT

Technical University of Munich

Phase 2 Withdrawn

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡